These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6329575)

  • 21. Akathisia: clinical phenomenology and relationship to tardive dyskinesia.
    Kahn EM; Munetz MR; Davies MA; Schulz SC
    Compr Psychiatry; 1992; 33(4):233-6. PubMed ID: 1353716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical variants of tardive dyskinesia in Japan.
    Inada T; Yagi G; Kaijima K; Ohnishi K; Kamisada M; Rockhold RW
    Jpn J Psychiatry Neurol; 1991 Mar; 45(1):67-71. PubMed ID: 1753492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of tardive akathisia with clonidine.
    Nishikawa T; Koga I; Uchida Y; Tanaka M
    Kurume Med J; 1990; 37(3):185-7. PubMed ID: 1980934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous diazepam in the treatment of neuroleptic-induced acute dystonia and akathisia.
    Gagrat D; Hamilton J; Belmaker RH
    Am J Psychiatry; 1978 Oct; 135(10):1232-3. PubMed ID: 29498
    [No Abstract]   [Full Text] [Related]  

  • 25. Akathisia, pseudoakathisia and tardive dyskinesia: clinical examples.
    Munetz MR; Cornes CL
    Compr Psychiatry; 1982; 23(4):345-52. PubMed ID: 6126315
    [No Abstract]   [Full Text] [Related]  

  • 26. Late-onset akathisia--an indicant of covert dyskinesia: two case reports.
    Braude WM; Barnes TR
    Am J Psychiatry; 1983 May; 140(5):611-2. PubMed ID: 6133460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noradrenergic effects in tardive dyskinesia, akathisia and pseudoparkinsonism via the limbic system and basal ganglia.
    Wilbur R; Kulik FA; Kulik AV
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(6):849-64. PubMed ID: 2907387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical forms of severe tardive dyskinesia.
    Gardos G; Cole JO; Salomon M; Schniebolk S
    Am J Psychiatry; 1987 Jul; 144(7):895-902. PubMed ID: 2886062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tardive dyskinesia in patients receiving lithium maintenance therapy.
    Perényi A; Szücs R; Frecska E
    Biol Psychiatry; 1984 Nov; 19(11):1573-8. PubMed ID: 6151403
    [No Abstract]   [Full Text] [Related]  

  • 30. Propranolol in the treatment of neuroleptic-induced akathisia.
    Lipinski JF; Zubenko GS; Cohen BM; Barreira PJ
    Am J Psychiatry; 1984 Mar; 141(3):412-5. PubMed ID: 6142657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacologic treatment of neuroleptic-induced akathisia.
    Fleischhacker WW; Roth SD; Kane JM
    J Clin Psychopharmacol; 1990 Feb; 10(1):12-21. PubMed ID: 1968470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevalence of akathisia in patients receiving stable doses of clozapine.
    Chengappa KN; Shelton MD; Baker RW; Schooler NR; Baird J; Delaney J
    J Clin Psychiatry; 1994 Apr; 55(4):142-5. PubMed ID: 7915271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of akathisia with lorazepam. An open clinical trial.
    Bartels M; Heide K; Mann K; Schied HW
    Pharmacopsychiatry; 1987 Mar; 20(2):51-3. PubMed ID: 2884681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of tardive dyskinesia and mania with RBC lithium determinations.
    Ereshefsky L; Rubin TN; Friedman S
    Am J Psychiatry; 1979 Apr; 136(4B):570-3. PubMed ID: 34329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tardive akathisia and agitated depression during metoclopramide therapy.
    Shearer RM; Bownes IT; Curran P
    Acta Psychiatr Scand; 1984 Nov; 70(5):428-31. PubMed ID: 6516892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tardive Parkinsonism, orofacial dyskinesia and akathisia following brief exposure to lithium carbonate.
    Muthane UB; Prasad BN; Vasanth A; Satishchandra P
    J Neurol Sci; 2000 May; 176(1):78-9. PubMed ID: 10960299
    [No Abstract]   [Full Text] [Related]  

  • 37. [Tardive dyskinesia: etiology, clinical features and therapy].
    Furer V; Lichtenberg P; Heresco-Levy U
    Harefuah; 2001 Mar; 140(3):248-52. PubMed ID: 11303354
    [No Abstract]   [Full Text] [Related]  

  • 38. Neuroleptic use, parkinsonian symptoms, tardive dyskinesia, and associated factors in child and adolescent psychiatric patients.
    Richardson MA; Haugland G; Craig TJ
    Am J Psychiatry; 1991 Oct; 148(10):1322-8. PubMed ID: 1680296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of long-term neuroleptanxiolysis with fluspirilene 1.5 mg per week.
    Tegeler J; Lehmann E; Weiher A; Heinrich K
    Pharmacopsychiatry; 1990 Nov; 23(6):259-64. PubMed ID: 2284327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early extrapyramidal side-effects as risk factors for later tardive dyskinesia: a prospective study.
    Sachdev P
    Aust N Z J Psychiatry; 2004 Jun; 38(6):445-9. PubMed ID: 15209837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.